Patents Assigned to Eyed Pharma
  • Eye device
    Patent number: 9999595
    Abstract: The invention provides a sustained release intraocular drug delivery device comprising: (a) a polymeric matrix core into which at least one therapeutic agent is mixed, and; (b) a polymeric coating completely surrounding said polymeric matrix material; wherein said polymeric matrix core and polymeric coating are insoluble and inert in ocular fluids, and wherein said sustained release intraocular drug delivery device has a compliant annular segment shape and is to be inserted into the sulcus of the intact and/or pseudophakic eye.
    Type: Grant
    Filed: November 14, 2014
    Date of Patent: June 19, 2018
    Assignee: EYED PHARMA
    Inventors: Jean-Marie Rakic, Jean-Michel Foidart
  • EYE DEVICE
    Publication number: 20160287513
    Abstract: The invention provides a sustained release intraocular drug delivery device comprising: (a) a polymeric matrix core into which at least one therapeutic agent is mixed, and; (b) a polymeric coating completely surrounding said polymeric matrix material; wherein said polymeric matrix core and polymeric coating are insoluble and inert in ocular fluids, and wherein said sustained release intraocular drug delivery device has a compliant annular segment shape and is to be inserted into the sulcus of the intact and/or pseudophakic eye.
    Type: Application
    Filed: November 14, 2014
    Publication date: October 6, 2016
    Applicant: Eyed Pharma
    Inventors: Jean-Marie Rakic, Jean-Michel Foidart